Stock GEHC * GE HEALTHCARE TECHNOLOGIES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials GE HealthCare Technologies Inc. Mexican S.E.

Equities

GEHC *

US36266G1076

Advanced Medical Equipment & Technology

End-of-day quote Mexican S.E.
Other stock markets
 18:00:00 2024-06-19 EDT 		5-day change 1st Jan Change
1,336 MXN -6.36% Intraday chart for GE HealthCare Technologies Inc. -6.36% +4.39%
06-20 GE HealthCare, MediView Report Clinical Use of OmnifyXR Interventional Suite MT
06-20 GE Healthcare and Mediview Announce the World's First Installation and Clinical Use of Augmented Reality Interventional Suite That Aims to Transform the Practice of Interventional Radiology CI

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 26,546 35,199 36,138 - -
Enterprise Value (EV) 1 33,350 42,137 41,355 39,302 36,949
P/E ratio 14 x 25.4 x 19.5 x 17.2 x 15.3 x
Yield - - 0.12% 0.19% 0.25%
Capitalization / Revenue 1.45 x 1.8 x 1.79 x 1.71 x 1.62 x
EV / Revenue 1.82 x 2.16 x 2.05 x 1.86 x 1.66 x
EV / EBITDA 10.6 x 11.8 x 11.3 x 9.91 x 8.69 x
EV / FCF - 24.6 x 22.5 x 24.2 x 11.9 x
FCF Yield - 4.07% 4.44% 4.14% 8.4%
Price to Book - 4.94 x 4.27 x 3.38 x 2.82 x
Nbr of stocks (in thousands) 454,710 455,243 456,465 - -
Reference price 2 58.38 77.32 79.17 79.17 79.17
Announcement Date 23-01-30 24-02-06 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 18,341 19,552 20,165 21,160 22,286
EBITDA 1 3,155 3,566 3,675 3,966 4,252
EBIT 1 2,522 2,956 3,163 3,446 3,775
Operating Margin 13.75% 15.12% 15.69% 16.28% 16.94%
Earnings before Tax (EBT) 1 2,512 2,361 2,551 2,889 3,223
Net income 1 1,916 1,568 1,858 2,119 2,360
Net margin 10.45% 8.02% 9.21% 10.01% 10.59%
EPS 2 4.180 3.040 4.059 4.607 5.175
Free Cash Flow 1 - 1,714 1,837 1,626 3,103
FCF margin - 8.77% 9.11% 7.69% 13.92%
FCF Conversion (EBITDA) - 48.07% 49.98% 41.01% 72.97%
FCF Conversion (Net income) - 109.31% 98.86% 76.76% 131.51%
Dividend per Share 2 - - 0.0933 0.1466 0.2000
Announcement Date 23-01-30 24-02-06 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 4,576 4,938 4,707 4,817 4,822 5,206 4,650 4,883 5,067 5,542 4,911 5,150
EBITDA 1 - - - - 808 981 749 890.4 959.1 1,093 905.7 -
EBIT 1 - 777 664 711 744 837 681 738.5 807.1 945 751.6 807.3
Operating Margin - 15.74% 14.11% 14.76% 15.43% 16.08% 14.65% 15.12% 15.93% 17.05% 15.3% 15.67%
Earnings before Tax (EBT) 1 - 718 546 570 636 609 512 587 671.3 800.3 603 660.7
Net income 1 487 554 189 418 375 403 374 424.1 479.3 581.4 462.8 491.7
Net margin 10.64% 11.22% 4.02% 8.68% 7.78% 7.74% 8.04% 8.69% 9.46% 10.49% 9.42% 9.55%
EPS 2 - 1.210 0.4100 0.9100 0.8200 0.8800 0.8100 0.9125 1.031 1.254 0.9825 1.067
Dividend per Share - - - 0.0600 0.0300 - - - - - - -
Announcement Date 22-11-07 23-01-30 23-04-25 23-07-25 23-10-31 24-02-06 24-04-30 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 6,804 6,938 5,217 3,164 810
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) 2.157 x 1.946 x 1.42 x 0.7977 x 0.1906 x
Free Cash Flow 1 - 1,714 1,837 1,626 3,103
ROE (net income / shareholders' equity) - 19% 24.6% 23.7% 21.9%
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2 - 15.70 18.50 23.50 28.10
Cash Flow per Share 2 - 4.590 4.840 5.970 6.870
Capex 1 310 387 393 415 426
Capex / Sales 1.69% 1.98% 1.95% 1.96% 1.91%
Announcement Date 23-01-30 24-02-06 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for GE HealthCare Technologies Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
79.17 USD
Average target price
92.74 USD
Spread / Average Target
+17.14%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+6.37% 216B
DANAHER CORPORATION Stock Danaher Corporation
+10.21% 189B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+28.22% 153B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+34.42% 114B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.80% 63.2B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+19.21% 54.78B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+0.13% 48.47B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-4.16% 38.88B
RESMED, INC. Stock ResMed, Inc.
+19.65% 30.23B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. GEHC Stock
  4. GEHC * Stock
  5. Financials GE HealthCare Technologies Inc.